Tags

Type your tag names separated by a space and hit enter

[Antiviral agents in influenza--current recommendations. Anti-influenza agents are not a substitution for but a complement to vaccination].
Lakartidningen. 2005 Dec 5-11; 102(49):3802-3, 3805-6, 3808.L

Abstract

This article summarizes a Swedish consensus guidance document on the use of antiviral drugs in the management of influenza. Vaccination remains the cornerstone for influenza prophylaxis. Treatment with neuraminidase inhibitors is recommended for high-risk groups and individuals hospitalised with influenza. Chemoprophylaxis is targeted at high-risk groups and should be considered on a case by case basis depending on the circumstances. Unvaccinated at-risk patients or seasonal vaccine strain mismatch were identified as potential indications for antiviral prophylaxis. Oseltamivir prophylaxis can otherwise be considered for influenza in a household including an at-risk individual and in outbreaks in hospitals and nursing homes. The use of antivirals in a pandemic situation is also discussed.

Authors+Show Affiliations

Infektionskliniken, Akademiska sjukhuset, avdelningen for klinik och preklinik 1, Läkemedelsverket, Uppsala. ingrid.uhnoo@mpa.seNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Review

Language

swe

PubMed ID

16408704

Citation

Uhnoo, Ingrid, and Annika Linde. "[Antiviral Agents in Influenza--current Recommendations. Anti-influenza Agents Are Not a Substitution for but a Complement to Vaccination]." Lakartidningen, vol. 102, no. 49, 2005, pp. 3802-3, 3805-6, 3808.
Uhnoo I, Linde A. [Antiviral agents in influenza--current recommendations. Anti-influenza agents are not a substitution for but a complement to vaccination]. Lakartidningen. 2005;102(49):3802-3, 3805-6, 3808.
Uhnoo, I., & Linde, A. (2005). [Antiviral agents in influenza--current recommendations. Anti-influenza agents are not a substitution for but a complement to vaccination]. Lakartidningen, 102(49), 3802-3, 3805-6, 3808.
Uhnoo I, Linde A. [Antiviral Agents in Influenza--current Recommendations. Anti-influenza Agents Are Not a Substitution for but a Complement to Vaccination]. Lakartidningen. 2005 Dec 5-11;102(49):3802-3, 3805-6, 3808. PubMed PMID: 16408704.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Antiviral agents in influenza--current recommendations. Anti-influenza agents are not a substitution for but a complement to vaccination]. AU - Uhnoo,Ingrid, AU - Linde,Annika, PY - 2006/1/18/pubmed PY - 2006/1/18/medline PY - 2006/1/18/entrez SP - 3802-3, 3805-6, 3808 JF - Lakartidningen JO - Lakartidningen VL - 102 IS - 49 N2 - This article summarizes a Swedish consensus guidance document on the use of antiviral drugs in the management of influenza. Vaccination remains the cornerstone for influenza prophylaxis. Treatment with neuraminidase inhibitors is recommended for high-risk groups and individuals hospitalised with influenza. Chemoprophylaxis is targeted at high-risk groups and should be considered on a case by case basis depending on the circumstances. Unvaccinated at-risk patients or seasonal vaccine strain mismatch were identified as potential indications for antiviral prophylaxis. Oseltamivir prophylaxis can otherwise be considered for influenza in a household including an at-risk individual and in outbreaks in hospitals and nursing homes. The use of antivirals in a pandemic situation is also discussed. SN - 0023-7205 UR - https://www.unboundmedicine.com/medline/citation/16408704/[Antiviral_agents_in_influenza__current_recommendations__Anti_influenza_agents_are_not_a_substitution_for_but_a_complement_to_vaccination]_ DB - PRIME DP - Unbound Medicine ER -